{"id":2672,"date":"2017-07-20T09:39:13","date_gmt":"2017-07-20T09:39:13","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=25604"},"modified":"2017-07-20T09:39:13","modified_gmt":"2017-07-20T09:39:13","slug":"medical-marijuana-inc-subsidiary-hempmeds-brasil-garners-vast-media-coverage-across-brazil-company-cannabis-market-growth","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/07\/20\/medical-marijuana-inc-subsidiary-hempmeds-brasil-garners-vast-media-coverage-across-brazil-company-cannabis-market-growth\/","title":{"rendered":"Medical Marijuana, Inc. and Subsidiary HempMeds Brasil\u2122 Garners Vast Media Coverage Across Brazil of Company and Cannabis Market Growth"},"content":{"rendered":"
\n
\n

SAN DIEGO<\/span>, July 20, 2017<\/span> \/PRNewswire\/ —\u00a0Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States<\/span>, today announced that it and its subsidiary HempMeds\u00ae Brasil<\/a> garnered extensive media coverage across Brazil<\/span> about the Company’s growth and the booming cannabis market across U.S. and Latin America<\/span>.<\/p>\n

A July 16, 2017<\/span> article from Rio de Janeiro<\/span>-based Brazilian newspaper O Globo “Neg\u00f3cios que d\u00e3o a maior onda”, or “In the cannabis market, these businesses will get you high”<\/a>, which was picked up by several other major news outlets across the Country, discussed the explosive growth projected for the cannabis market in the U.S. and Latin America<\/span> and recent advances in legislation. The article also featured a global AFP photo of Medical Marijuana, Inc.’s products<\/a> taken at the 4th<\/sup> Annual Cannabis World Congress and Business Expo in New York City<\/span> in June 2017<\/span>.<\/p>\n

“It’s encouraging to see the widespread global media coverage of the medical marijuana and CBD markets; we are always pleased to be at the forefront of discussion of one of the fastest growing industries in the world,” said CEO of Medical Marijuana, Inc. Dr. Stuart Titus<\/span>. “A goal of our company has been to provide an alternative health-and-wellness approach to those who may fail conventional medical treatment.”<\/p>\n

“Brazil<\/span>, a nation willing to challenge convention and explore botanical remedies that may provide health-and-wellness benefits, has set forth progress in terms of botanical cannabinoids – and many Brazil<\/span>-national families have seen the benefits. We appreciate that the recent press coverage is helping educate the people of Brazil<\/span> and the world,” added Dr. Titus.<\/p>\n

HempMeds Brasil\u2122<\/a> is the first company to offer legal medicinal cannabis products to\u00a0Brazil\u00a0after receiving import approval to those suffering from specific medical conditions. Most recently in February 2017<\/span>, for the filling of a prescription for the first time for the Company’s hemp CBD oil product Real Scientific Hemp Oil\u2122 (RSHO\u2122)<\/a>\u00a0to treat patients in the country suffering from Multiple Sclerosis. Additionally, doctors in Brazil<\/span> can prescribe RSHO\u2122 for any condition and HempMeds Brasil\u2122<\/a> has worked with several cases including patients suffering from:<\/p>\n